Cure My Disease

Don't miss your cure!

 Log in / Sign up

Ancient gold remedy put to the test for Children's immune health

NCT ID NCT07724561

Not yet recruiting Prevention Sponsor: National Ayurveda Research and Training Center Source: ClinicalTrials.gov ↗

First seen Jul 24, 2026 · Last updated Jul 24, 2026

Summary

This pilot study in Nepal is testing whether suvarnaprashana — a traditional Ayurvedic preparation made with purified gold, honey, and ghee — is safe and may strengthen the immune system in healthy children aged 2 to 5 years. Over 8 weeks, researchers will monitor for side effects and measure changes in immune markers like antibody levels and T-cell counts. The goal is to gather early evidence that could justify larger trials and potentially offer a simple way to help children fight off common infections.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
an Ayurvedic gold-based formulation (suvarnaprashana) containing purified gold, honey, and clarified butter (ghee), taken orally once daily for 30 days
What this could lead to
If safe and effective, this traditional remedy could offer a simple way to support children's immune health and reduce common infections.
What could go wrong
This is a very small pilot study (40 children) with no blinding, so results may not be reliable. Gold-based products also carry unknown risks in young children.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY CHILDREN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY CHILDREN IMMUNE FUNCTION IMMUNOMODULATION

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.